Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus

Angiology

Volumn 65, Issue 2, 2014, Pages 154-159

  Ekmekci, Ahmet ^a   Cicek, Gokhan ^b   Uluganyan, Mahmut ^c   Gungor, Baris ^a   Osman, Faizel ^d   Ozcan, Kazim Serhan ^a   Bozbay, Mehmet ^a   Ertas, Gokhan ^a   Zencirci, Aycan ^a   Sayar, Nurten ^a   Eren, Mehmet ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Kadirli State Hospital   (Turkey)

^d UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

hyperglycemia; major adverse cardiac events; mortality; ST segment elevation myocardial infarction

Indexed keywords

CREATINE KINASE MB; CREATININE; GLUCOSE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84891856747     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713488930     Document Type: Article

References (41)

1. Del Olmo MI, Merino-Torres JF, Argente M, et al. Detection of glucose abnormalities in patients with acute coronary heart disease: study of reliable tools in clinical practice [published online May 30, 2011]. J Endocrinol Invest. 2011 ;:
2. Ramachandran A, Chamukuttan S, Immaneni S, et al. High incidence of glucose intolerance in Asian-Indian subjects acute coronary syndromes. Diabetes Care. 2005 ; 28 (10). 2492-2496
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial systemic infarction in patients with and without diabetes: an overview. Lancet. 2000 ; 355 (9206). 773-778
4. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Eng J Med. 1998 ; 339 (4). 229-243
5. Nurkalem Z, Hasdemir H, Ergelen M, et al. The relationship between glucose tolerance and severity of coronary artery disease using the Gensini score. Angiology. 2010 ; 61 (8). 751-75
6. Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Weiss MB. Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006 ; 97 (7). 968-969
7. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001 ; 17 (1). 107
8. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care. 1999 ; 22 (11). 1827-1831
9. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: longterm results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation. 1999 ; 99 (20). 2626-2632
10. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989 ; 2 (5). 358-367
11. Damman P, Kampinga MA, van der Horst IC, et al. Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration [published online September 30 2012]. J Thromb Thrombolysis. 2012 ;:
12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 ; 76 (1). 142-154
13. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two-year experience with 250 patients. Am J Cardiol. 1967 ; 20 (4). 457-464
14. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypo-glycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005 ; 26 (13). 1255-1261
15. Timmer JR, van der Horst IC, Ottervanger JP, et al. Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004 ; 148 (3). 399-404
16. Allison SP, Tomlin PJ, Chamberlain MJ. Some effects of anaesthesia and surgery on carbohydrate and fat metabolism. Br J Anaesth. 1969 ; 41 (7). 588-592
17. Clarke RS, Johnston H, Sheridan B. The influence of anaesthesis and surgery on plasma cortisol, insulin and free fatty acids. Br J Anaesth. 1970 ; 42 (4). 295-299
18. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrythmias. Lancet. 1994 ; 343 (8890). 155-158
19. Brunetti ND, Sai R, Correale M, De Gennaro L, Di Biase M. Inflammatoryactivation is related to glucose impairment in diabetics with acute myocardial infarction [published online October 24, 2012]. Int J Cardiol. 2012 ;:
20. Giugliano D, Marfella R, Coppola R, et al. Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997 ; 95 (7). 1783-1790
21. Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D. The effect of acute hyperglycemia on QTc duration in healthy man. Diabetologia. 2000 ; 43 (5). 571-575
22. Jensen CJ, Eberle HC, Nassenstein K, et al. Impact of hyperglycaemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol. 2011 ; 100 (8). 649-659
23. Eitel I, Hintze S, de Waha S, et al. Prognostic impact of hyperglycemia in non-diabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging. Circ Cardiovasc Imaging. 2012 ; 5 (6). 708-718
24. Hoebers LP, Damman P, Claessen BE, et al. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2012 ; 109 (1). 53-59
25. Hsu CW, Chen HH, Sheu WH, et al. Initial serum glucose level as a prognostic factor in the first acute myocardial infarction. Ann Emerg Med. 2007 ; 49 (5). 618-626
26. Straumann E, Kurz DJ, Muntwyler J, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J. 2005 ; 150 (5). 1000-1006
27. Knudsen EC, Seljeflot I, Abdelnoor M, et al. Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol. 2009 ; 8: 6
28. Takada JY, Ramos RB, Roza LC, et al. In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women. Cardiovasc Diabetol. 2012 ; 11: 47
29. Pinto DS, Skolnick AH, Kirtane AJ, et al. TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 ; 46 (1). 178-180
30. Yang SW, Zhou YJ, Liu YY, et al. Beijing Elderly Acute Myocardial Infarction Study (BEAMIS) Group. Influence of abnormal fasting plasma glucose on left ventricular function in older patients with acute myocardial infarction. Angiology. 2012 ; 63 (4). 266-274
31. Peter R., Sinnaeve PR, Steg PG, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes. Arch Intern Med. 2009 ; 169 (4). 402-409
32. Ishihara M, Kagawa E, Inoue I, et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol. 2007 ; 99 (12). 1674-1679
33. Rasoul S, Ottervanger JP, Bilo HJ, et al. Glucose dysregulation in non-diabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI. Neth J Med. 2007 ; 65 (3). 95-100
34. Sekiyama H, Nagoshi T, Komukai K, et al. Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: paradoxical contribution of plasma glucose level and glycohemoglobin. Cardiovasc Diabetol. 2013 ; 12: 4
35. Su G, Mi SH, Tao H, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013 ; 36 (4). 1026-1032
36. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005 ; 26 (7). 650-661
37. Malmberg K. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Endocr Pract. 2004 ; 10: 13-16
38. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005 ; 293 (4). 437-446
39. van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucose-insulin- potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin potassium study: a randomized trial. J Am Coll Cardiol. 2003 ; 42 (5). 784-791
40. Hyperglycaemia in Acute Coronary Syndromes: Management of Hyperglycaemia in People with Acute Coronary Syndromes. London, UK: National Institute for Health and Clinical Excellence (UK ; 2011 :
41. Goyal A, Mehta SR, Diaz R, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009 ; 120 (24). 2429-2437